ADVANCED GASTRIC-CANCER - COMPARISON OF FAMTX (5-FU, ADRIAMYCINE, METHOTREXATE) VERSUS ELF (ETROPOSIDE, 5-FU, LEUCOVORIN) VERSUS FUP (INFUSIONAL 5-FU PLUS CISPLATIN) - RESULTS FROM AN EORTC TRIAL OF THE GITCCGAND THE ARBEITSGEMEINSCHAFT FUR INNERE ONKOLOGIE (AIO)

Authors
ROUGIER P WILS J WILKE H LACAVE A VANCUTSEM E VANHOFER U SAHMOUD T CURRAN D MARINUS A
Citation
P. Rougier et al., ADVANCED GASTRIC-CANCER - COMPARISON OF FAMTX (5-FU, ADRIAMYCINE, METHOTREXATE) VERSUS ELF (ETROPOSIDE, 5-FU, LEUCOVORIN) VERSUS FUP (INFUSIONAL 5-FU PLUS CISPLATIN) - RESULTS FROM AN EORTC TRIAL OF THE GITCCGAND THE ARBEITSGEMEINSCHAFT FUR INNERE ONKOLOGIE (AIO), European journal of cancer, 31A, 1995, pp. 546-546
Citations number
2
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
31A
Year of publication
1995
Supplement
5
Pages
546 - 546
Database
ISI
SICI code
0959-8049(1995)31A:<546:AG-COF>2.0.ZU;2-F